Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

ClinicalTrials.gov ID: NCT02512588

Public ClinicalTrials.gov record NCT02512588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Study identification

NCT ID
NCT02512588
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Balance Therapeutics
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • BTD-001 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Jan 31, 2018
Completion
Jan 31, 2018
Last update posted
Jan 15, 2019

2015 – 2018

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213
Stanford Medicine Sleep Center Palo Alto California 94304
Pacific Research Network San Diego California 92103
Empire Clinical Research Upland California 91786
REM Sleep Medicine, Colorado Sleep Institute Boulder Colorado 80301
PAB Clinical Research Brandon Florida 33511
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707
Emory University School of Medicine Emory Sleep Center Atlanta Georgia 30329
NeuroTrials Research Inc Atlanta Georgia 30342
SleepMed of Central Macon Georgia 31201
Kentucky Research Group, Louisville Kentucky 40218
The Center for Sleep and Wake Disorders Chevy Chase Maryland 20815
NeuroCare Center for Sleep Newton Massachusetts 02459
Neurological Associate Maplewood Minnesota 55109
Clayton Sleep Institute St Louis Missouri 63143
Columbia University Medical Center New York New York 10032
Wake Research Associates Raleigh North Carolina 27612
Community Research Management Assoc. Cincinnati Ohio 45255
Lynn Institute Oklahoma City Oklahoma 73112
SleepMed of South Carolina Columbia South Carolina 29201
Future Search Trials of Neurology Austin Texas 78731
Houston Sleep Center Houston Texas 77063
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02512588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02512588 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →